Altered Dopamine Receptor and Dopamine Transporter Binding and Tyrosine Hydroxylase mRNA Expression Following Perinatal NMDA Receptor Blockade
This study examined how perinatal phencyclidine (PCP) treatment would affect dopamine D 2 receptor and dopamine transporter (DAT) binding at different stages after treatment cessation. Female rat pups received injections of PCP (10 mg/kg, s.c.) or saline on postnatal day (PN)7, 9 and 11. D 2 recepto...
Saved in:
Published in | Neurochemical research Vol. 33; no. 7; pp. 1224 - 1231 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.07.2008
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study examined how perinatal phencyclidine (PCP) treatment would affect dopamine D
2
receptor and dopamine transporter (DAT) binding at different stages after treatment cessation. Female rat pups received injections of PCP (10 mg/kg, s.c.) or saline on postnatal day (PN)7, 9 and 11. D
2
receptor and transporter binding was examined at four time-points (PN12, 18, 32 and 96) following injections. PCP treatment altered D
2
receptor binding throughout development, with a final end-point of 22–33% decreased binding at adulthood in the nucleus accumbens and caudate putamen (
P
< 0.01), accompanied by a small but significant increase in DAT binding in the caudate putamen. Tyrosine hydroxylase mRNA expression was also significantly increased by 25% (
P
< 0.05) in the ventral tegmental area of adult rats, suggesting that this model may produce a long-term increase in dopamine output. This study demonstrates that early insult to the brain from NMDA receptor hypofunction alters the dopaminergic system at different stages of development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0364-3190 1573-6903 |
DOI: | 10.1007/s11064-007-9571-y |